You searched for metabolic diseases - Page 24 of 62

News and Trends 11 Jul 2023

Inhaled mRNA medicines redefine respiratory disease treatment

…what opportunities do inhaled mRNA medicines offer for the treatment of respiratory diseases? Inhaled mRNA medicines provide several opportunities in the treatment of respiratory diseases. Firstly, they offer a localized…

July 11, 2023 - 3 minutesmins - By External Contributor

Libra Therapeutics, the virtual biotech company using data to boost CNS drug development

How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases

Libra Therapeutics is a San Diego-based biotech focused on developing novel disease-modifying therapeutics, which restore the cellular balance that is disrupted in neurodegenerative diseases. Established in 2020, Libra is leveraging…

February 25, 2025 - 9 minutesmins - By External Contributor

News and Trends 26 Apr 2023

Global partners announce The Big Catch-up vaccination effort

…helps vaccinate half the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped to immunize a whole generation – more than 981…

April 26, 2023 - 5 minutesmins - By Jim Cornall

Best in Biotech 2 Aug 2024

Six epigenetics companies making strides in 2024

…result in the development of diseases like cancer, making these enzymes an ideal drug target. British spinout Storm Therapeutics is developing RNA-modifying enzyme inhibitors to tackle a range of diseases….

August 2, 2024 - 7 minutesmins - By Roohi Mariam Peter

Podcast 23 Feb 2024

Precision neuromedicine: A new dawn for neurological disorders

…to current treatments for neurological and psychiatric diseases. Current treatments often come with reduced efficacy and side effects that lead to suboptimal dosing, noncompliance and discontinuation. By more precisely targeting…

February 23, 2024 - 6 minutesmins - By Jim Cornall

Best in Biotech 14 Jan 2025

Singapore’s biotech scene: 7 companies leading the way in 2025

…biomarker for external clinical compounds that has reached the clinical stages. Engine’s biology search platform, called NetMAPPR, maps biological networks and reveals critical genetic and molecular interactions integral to diseases,…

January 14, 2025 - 11 minutesmins - By Willow Shah-Neville

In Depth 9 Jun 2023

Enhancing canine wellness: The promise of immunotherapy for dogs

…treat allergic diseases in dogs has been around for several decades now, but there has been a surge of interest and research aimed at harnessing the power of the immune…

June 9, 2023 - 8 minutesmins - By Willow Shah-Neville

Best in Biotech 13 Jun 2024

Eight companies tackling cancer with allogeneic cell therapy in 2024

…as cancer, cardiovascular diseases, autoimmune disorders, and genetic diseases. The market size was valued at $255.6 million in 2022, and is expected to grow at a compound annual growth rate…

June 13, 2024 - 9 minutesmins - By Jules Adam

In Depth 24 Jan 2024

A new chapter in cell therapy: engineered B cells reach the clinic for the first time

Cell therapy has drastically improved the scope of treatment for a number of diseases in the last few years. Now, engineered B cells are the latest approach in the field…

January 24, 2024 - 7 minutesmins - By Willow Shah-Neville

More News! 11 Sep 2017

Could a Protein in Yeast hold the Secret to Escaping Age-Related Diseases?

…is found in animals and humans too, could help to overcome age-related diseases. During the study, yeast cells were exposed to different stress conditions and lifespan, protein synthesis and Gcn4…

September 11, 2017 - 2 minutesmins - By Alex Dale

Interview 25 Apr 2019

European Biotechnology in 2019 and Beyond: What’s Hot and What’s Not?

…there still room for more development in this somewhat crowded area? Eric Tauber, CEO of Themis Bioscience, an Austrian biotech that focuses on vaccines for infectious diseases and cancer, believes…

April 25, 2019 - 11 minutesmins - By Helen Albert

News and Trends 4 Aug 2022

Deal worth $3.7B sealed as Amgen buys biopharma ChemoCentryx

A company producing drugs including TAVNEOS to treat autoimmune diseases, plus others dealing with inflammatory disorders and cancer has been bought by biopharmaceutical company, Amgen for $52 per share. ChemoCentryx…

August 4, 2022 - 3 minutesmins - By Liza Laws

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Inhaled mRNA medicines redefine respiratory disease treatment

How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases

Global partners announce The Big Catch-up vaccination effort

Six epigenetics companies making strides in 2024

Precision neuromedicine: A new dawn for neurological disorders

Singapore’s biotech scene: 7 companies leading the way in 2025

Enhancing canine wellness: The promise of immunotherapy for dogs

Eight companies tackling cancer with allogeneic cell therapy in 2024

A new chapter in cell therapy: engineered B cells reach the clinic for the first time

Could a Protein in Yeast hold the Secret to Escaping Age-Related Diseases?

European Biotechnology in 2019 and Beyond: What’s Hot and What’s Not?

Deal worth $3.7B sealed as Amgen buys biopharma ChemoCentryx

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!